#USA #Manufacturing #Biopharmaceutical #Wilson #ABEC

ABEC Expands Its Footprint with New Facility in Wilson, North Carolina

On September 10, 2026, ABEC, a global frontrunner in customized solutions for biopharmaceutical manufacturing, announced the opening of its latest manufacturing plant located in Wilson, North Carolina. The official inauguration ceremony is set to take place on September 24, 2026, at 9 AM, gathering company executives, employees, partners, and local officials to celebrate this significant milestone in ABEC's growth journey.

The Wilson facility enhances ABEC's existing global production network, enabling the company to better meet the growing demands of the expanding biopharmaceutical sector. This state-of-the-art facility will provide advanced equipment, consumables, and integrated process solutions essential for the development and manufacturing of biological products, vaccines, and other vital therapies.

Strategically positioned in one of the fastest-growing life sciences regions in the country, the new site not only boosts ABEC’s production capabilities but also aims to create numerous high-quality jobs in manufacturing and technical fields across Eastern North Carolina. Scott Pickering, the CEO of ABEC, emphasized the company's commitment to supporting the global biopharmaceutical industry, stating, "The inauguration of our Wilson site marks a significant new chapter in our commitment to the biopharmaceutical sector. This investment allows us to enhance our manufacturing capabilities, bring us closer to our Southeast U.S. clients, and strengthen our ability to offer the most comprehensive range of bioprocessing equipment, consumables, and engineering solutions in the industry. We are proud to join the Wilson community and look forward to forging strong partnerships throughout the region."

The Wilson facility will manufacture bioprocessing equipment and consumables aimed at advancing the development and production of life-saving biological products and innovative vaccines. This addition complements ABEC's existing production sites in Bethlehem, Pennsylvania, Springfield, Missouri, and Fermoy and Kells in Ireland, solidifying the company’s position as the premier global network for biopharmaceutical manufacturing solutions.

The inauguration event will include a ceremonial ribbon-cutting, guided tours of the facility, and speeches from ABEC's leaders alongside representatives from the local community. It will celebrate the collaborative efforts of employees, contractors, local partners, and elected officials whose support has made this project possible.

About ABEC

Since its inception in 1974, ABEC has established itself as a global leader in providing technical solutions and services for manufacturing processes within the biotechnology sector. Most pharmaceutical and biotechnology companies around the world are customers of ABEC, and many cutting-edge treatments in the market today are produced using ABEC-designed equipment and processes. ABEC's unique value proposition is based on extensive expertise, comprehensive in-house skills, flexible approaches, and long-standing credibility. From process development and facility design to equipment manufacturing, installation, and maintenance services, ABEC helps clients reduce costs and time to market while enhancing productivity.